Cleared Traditional

K092116 - EASYCELL CELL LOCATOR

K092116 is the FDA 510(k) clearance for EASYCELL CELL LOCATOR by Medica Corp.. It is a Class 2 Hematology device (product code JOY) cleared through the Traditional 510(k) pathway after a 302-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2010
Decision
302d
Days
Class 2
Risk

K092116 is an FDA 510(k) clearance for the EASYCELL CELL LOCATOR. Classified as Device, Automated Cell-locating (product code JOY), Class II - Special Controls.

Submitted by Medica Corp. (Beverly, US). The FDA issued a Cleared decision on May 12, 2010 after a review of 302 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5260 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Medica Corp. devices

Submission Details

510(k) Number K092116 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 14, 2009
Decision Date May 12, 2010
Days to Decision 302 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
189d slower than avg
Panel avg: 113d · This submission: 302d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JOY Device, Automated Cell-locating
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5260
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - JOY Device, Automated Cell-locating

All 7
Devices cleared under the same product code (JOY) and FDA review panel - the closest regulatory comparables to K092116.
CellaVision DC-1, CellaVision DC-1 PPA
K200595 · CellaVision AB · Oct 2020
X100 with Full Field Peripheral Blood Smear (PBS) Application
K201301 · Scopio Labs , Ltd. · Oct 2020
Sysmex UD-10, Fully Automated Urine Particle Digital Imaging Device
K182062 · Sysmex America, Inc. · Oct 2018
SCANNING SYS., AUTO. COMP., ACS1000
K772140 · Honeywell, Inc. · Dec 1977